Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. . J Natl Cancer Inst 2023 Feb 16:djad023. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. J Natl Cancer Inst 2023 Feb 16:djad023. doi: 10.1093.
PMID: 36795079